Genetic diversity and evolution of hepatitis C virus - 15 years on

被引:647
作者
Simmonds, P [1 ]
机构
[1] Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland
关键词
D O I
10.1099/vir.0.80401-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defences and the immune system. This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis. On one hand, diversification of HCV has been constrained by its intimate adaptation to its host. Despite the > 30 % nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development. Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defence pathways; this series of highly complex virus-host interactions may represent key components in establishing its 'ecological niche' in the human liver. On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires. If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants. These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.
引用
收藏
页码:3173 / 3188
页数:16
相关论文
共 151 条
[91]   The 2-5A system: Modulation of viral and cellular processes through acceleration of RNA degradation [J].
Player, MR ;
Torrence, PF .
PHARMACOLOGY & THERAPEUTICS, 1998, 78 (02) :55-113
[92]   Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response [J].
Polyak, SJ ;
Khabar, KSA ;
Paschal, DM ;
Ezelle, HJ ;
Duverlie, G ;
Barber, GN ;
Levy, DE ;
Mukaida, N ;
Gretch, DR .
JOURNAL OF VIROLOGY, 2001, 75 (13) :6095-6106
[93]   HEPATITIS-C VIREMIA IN RECIPIENTS OF IRISH INTRAVENOUS ANTI-D IMMUNOGLOBULIN [J].
POWER, JP ;
LAWLOR, E ;
DAVIDSON, F ;
YAP, PL ;
KENNYWALSH, E ;
WHELTON, MJ ;
WALSH, TJ .
LANCET, 1994, 344 (8930) :1166-1167
[94]   HCV:: epidemiology, modes of transmission and prevention of spread [J].
Pradat, P ;
Trépo, C .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (02) :201-210
[95]   The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: A Bayesian coalescent approach [J].
Pybus, OG ;
Drummond, AJ ;
Nakano, T ;
Robertson, BH ;
Rambaut, A .
MOLECULAR BIOLOGY AND EVOLUTION, 2003, 20 (03) :381-387
[96]   The epidemic behavior of the hepatitis C virus [J].
Pybus, OG ;
Charleston, MA ;
Gupta, S ;
Rambaut, A ;
Holmes, EC ;
Harvey, PH .
SCIENCE, 2001, 292 (5525) :2323-2325
[97]   Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy [J].
Quer, J ;
Murillo, P ;
Martell, M ;
Gómez, J ;
Esteban, JI ;
Esteban, R ;
Guardia, J .
JOURNAL OF VIRAL HEPATITIS, 2004, 11 (01) :45-54
[98]   Genetic epidemiology of hepatitis C virus throughout Egypt [J].
Ray, SC ;
Arthur, RR ;
Carella, A ;
Bukh, J ;
Thomas, DL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :698-707
[99]  
REISER M, 2004, 54 ANN M AM ASS STUD
[100]   Clinical features and progression of perinatally acquired hepatitis C virus infection [J].
Resti, M ;
Jara, P ;
Hierro, L ;
Azzari, C ;
Giacchino, R ;
Zuin, G ;
Zancan, L ;
Pedditzi, S ;
Bortolotti, F .
JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) :373-377